Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.

The PROSTaid group, which meets monthly at The Cradock Arms in Leicester, aims to create a support group for men so they can ...

Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...

Prostate cancer is the second-most common cancer in men. A new study from Thomas Jefferson University uncovered a new ...

New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate ...

ZERO Prostate Cancer (ZERO), announces the 2026 Veterans' Action Convening, a national gathering committed to strengthening ...

Join Tom and Mike as they share an important update on Tom's prostate cancer journey. In this video, they discuss Tom's ...

In a randomized trial of men with a single suspicious lesion on MRI, targeted perilesional biopsy matched standard targeted and systematic biopsy for detecting clinically significant prostate cancer - ...

Data from a major U.S. clinical trial from the Alliance for Clinical Trials in Oncology has uncovered a genetic factor that ...

An individual-patient meta-analysis sheds light on the optimal duration of androgen deprivation therapy in men with prostate cancer on definitive radiotherapy.

In a statement, NICE said the new guidance for Talzenna will make it an option for around 2,400 people in England and reduce ...

The Prostate Cancer Foundation has partnered with the Naismith Basketball Hall of Fame to host the launch of their “Check the ...